Position in ABBV
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$4,135,451
+$535,340 QoQ
Shares Held
16,434
-0.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.00%
of 13F equity value
Holder Rank
#1,431
of 4,150 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Key Financial Inc holds $18,745,925 across 16 Drug Manufacturers - General names. ABBV ranks #2 (22.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
25,096 | $6,373,630 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
16,434 | $4,135,451 | |
| 3 | MRK |
Merck & Co., Inc.
|
22,676 | $2,913,866 | |
| 4 | PFE |
Pfizer Inc
|
52,416 | $1,262,176 | |
| 5 | LLY |
ELI LILLY & Co
|
824 | $988,330 | |
| 6 | AZN |
Astrazeneca PLC
|
4,187 | $793,938 | |
| 7 | AMGN |
Amgen Inc
|
1,527 | $552,957 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
4,257 | $537,829 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,135,451 | 16,434 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $3,600,111 | 16,553 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $3,660,409 | 16,020 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $3,672,687 | 15,862 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $2,969,920 | 16,000 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $3,357,977 | 16,027 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $2,774,785 | 15,615 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $3,021,444 | 15,300 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $2,618,938 | 15,269 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $2,752,441 | 15,115 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,292,161 | 14,791 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $2,202,510 | 14,776 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $1,989,018 | 14,763 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $2,251,101 | 14,125 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $1,928,168 | 11,931 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $1,601,259 | 11,931 | Shares | Sole | 2022-10-28 | |
| 2022-06-30 | $993,089 | 6,484 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $1,038,800 | 6,408 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $810,639 | 5,987 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $644,631 | 5,976 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $673,136 | 5,976 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $634,710 | 5,865 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $611,290 | 5,705 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $508,459 | 5,805 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $560,116 | 5,705 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $415,159 | 5,449 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||